Dear Sir, In compliance with Regulation 44(3) of the SEBI (LODR) Regulations, 2015, we now attach herewith in the prescribed format, the details regarding the voting results of the business ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences Ltd has submitted the voting results of its 43rd AGM held on 25th September 2025 via video conferencing. Six resolutions were put to vote, and all were passed with overwhelming majority of approximately 99.53% in favor, with only 0.47% votes against. The resolutions included adoption of audited financial statements for FY ending 31st March 2025, re-appointment of Mr. Parikh H. A. as a director, regularization of two additional directors (one independent and one non-independent), appointment of a secretarial auditor for five years starting FY 2025-26, and alteration of the object clause of the company's Memorandum of Association. Total valid votes cast in favor were around 33 lakh shares, with about 15,500-15,600 votes against. No invalid votes were recorded.
This is a routine regulatory disclosure confirming that all AGM resolutions were approved by shareholders, so there is no negative impact on the stock. The alteration of the MOA's object clause signals a potential change in the company's business direction, which shareholders should monitor going forward.